Multiple Technology Appraisals (MTAs)
SCHARR-TAG has produced technology assessment reports since 2000. We are a dedicated team including experienced economic modellers, systematic reviewers, statisticians, information specialists and project managers.
- 2023
- 2021
- 2020
-
Non Bisphosphonates for Osteoporosis. Review of (TA160, TA161, TA204) [ID901].
- 2019
-
Cabozanitinib and vandatinib for advanced or metastatic medullary thyroid cancer [ID56].
- 2017
- 2016
-
Bisphosphonates for preventing osteoporotic fragility fractures [ID782].
- 2014
- 2013
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
-
Hormonal therapies for early breast cancer: systematic review and economic evaluation (03/20/01).
- 2006
-
Parent-training/education programmes in the management of children with conduct disorders (TA 102).
- 2005
- 2004
- 2003
-
Treatments for spasticity and pain in multiple sclerosis: a systematic review (99/05/03).
Human growth hormone (somatropin) in adults with growth hormone deficiency (TA 64).
- 2002
- 2001
- 2000
-
Liquid-based cytology in cervical screening: a rapid and systematic review (99/18/01).